How AI Agents, Data Strategy, and Organizational Change Are Reshaping the Future of Life Sciences
In This Episode
In this episode of the Life Sciences DNA Podcast, Shweta Maniar, Global Strategy and Market Leader for Life Sciences at Google Cloud, joins Nagaraja Srivatsan to discuss how AI agents, connected data ecosystems, and organizational transformation are reshaping the future of life sciences. The conversation explores why successful AI adoption requires more than advanced models — it demands strong data foundations, workflow redesign, and enterprise-wide alignment. Shweta also shares insights on scaling AI beyond pilot programs, the growing role of AI agents in scientific operations, and how biopharma organizations can unlock long-term value through responsible AI transformation.
Building the Foundation Before Scaling AI
Manyorganizations rush into AI experimentation without addressing fragmented dataecosystems and operational silos. Shweta discusses why scalable AItransformation begins with modernizing data architecture, governance, andorganizational alignment.
Why AI Is More Than an Efficiency Tool
Thediscussion reframes AI as a strategic capability that can de-risk science,accelerate decision-making, and improve collaboration across R&D, clinical,and commercial functions rather than simply automating repetitive tasks.
The Rise of AI Agents in Scientific Workflows
AI agentsare emerging as collaborators capable of orchestrating complex scientific andoperational tasks. The episode explores how multi-agent systems could transformknowledge work across life sciences organizations.
Organizational Change Is the Hardest Problem
Technologyis rarely the biggest blocker. Cultural resistance, workflow redesign, trust,and data readiness remain the primary challenges preventing organizations fromrealizing meaningful AI impact.
Moving Beyond Pilot Fatigue
Manyenterprises remain stuck in endless proof-of-concept cycles. Shweta sharespractical perspectives on prioritizing high-value use cases, aligningleadership, and creating repeatable AI adoption frameworks that scale.
The Future of AI-Driven Biopharma
Fromdiscovery through patient access, the conversation explores how AI-enabledecosystems may compress timelines, enhance scientific productivity, andredefine the future operating model for life sciences companies.
Transcript
Our Host
Nagaraja Srivatsan
Senior executive with over 30 years of experience driving digital transformation, AI, and analytics across global life sciences and healthcare. As CEO of endpoint Clinical, and former SVP & Chief Digital Officer at IQVIA R&D Solutions, Nagaraja champions data-driven modernization and eClinical innovation. He hosts the Life Sciences DNA podcast—exploring real-world AI applications in pharma—and previously launched strategic growth initiatives at EXL, Cognizant, and IQVIA. Recognized twice by PharmaVOICE as one of the “Top 100 Most Inspiring People” in life sciences
Our Speaker
Shweta Maniar
Global Strategy and Market Leader for Life Sciences at Google Cloud, Shweta Maniar works with biopharma organizations to modernize data and AI strategies that enable scalable innovation across research, development, and commercial operations.
Recent Episodes
